Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Mounjaro

Active ingredient: Tirzepatide

Neutral reference profile for an independent medicine-access consultancy enquiry about Mounjaro (Tirzepatide). No medicine is offered for sale.

NEXT STEP

Choose the strength and pack

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

RECORDED PRODUCT PROFILE

Mounjaro identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordMounjaro
Active ingredientTirzepatide
Dosage formsolution for injection in a pre-filled pen, solution for injection
Recorded options13
Directory areaEndocrinology
Catalogue synchronised

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

  1. 2.5 mg · 1 pen Catalogue organisation: LILLY DEUTSCHLAND GmbH
  2. 2.5 mg · 4 vials Catalogue organisation: LILLY DEUTSCHLAND GmbH
  3. 5 mg · 1 pen Catalogue organisation: LILLY DEUTSCHLAND GmbH
  4. 5 mg · 3 pens Catalogue organisation: LILLY DEUTSCHLAND GmbH
  5. 5 mg · 4 vials Catalogue organisation: LILLY DEUTSCHLAND GmbH
  6. 7.5 mg · 1 pen Catalogue organisation: LILLY DEUTSCHLAND GmbH
  7. 10 mg · 1 pen Catalogue organisation: LILLY DEUTSCHLAND GmbH
  8. 10 mg · 3 pens Catalogue organisation: LILLY DEUTSCHLAND GmbH
  9. 10 mg · 4 vials Catalogue organisation: LILLY DEUTSCHLAND GmbH
  10. 12.5 mg · 1 pen Catalogue organisation: LILLY DEUTSCHLAND GmbH
  11. 12.5 mg · 4 vials Catalogue organisation: LILLY DEUTSCHLAND GmbH
  12. 15 mg · 1 pen Catalogue organisation: LILLY DEUTSCHLAND GmbH
  13. 15 mg · 3 pens Catalogue organisation: LILLY DEUTSCHLAND GmbH

OFFICIAL SOURCES

Check the Mounjaro record at an official source.

Search for “Mounjaro” or “Tirzepatide”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.

SERVICE BOUNDARY

Information checking and independent enquiry support for Mounjaro.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Mounjaro

01What is Mounjaro?

This directory record associates the brand name Mounjaro with the active ingredient Tirzepatide. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Mounjaro strengths and packs are recorded?

The catalogue currently shows: 2.5 mg · 1 pen; 2.5 mg · 4 vials; 5 mg · 1 pen; 5 mg · 3 pens. Check the complete strength, dosage form and pack description against the prescription and medicine box.

03Who manufactures Mounjaro?

Catalogue records currently name: LILLY DEUTSCHLAND GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Mounjaro?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Mounjaro, payment request, stock guarantee or binding offer.

06Can I buy Mounjaro from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.